Micro-encapsulated lactobacilli for medical applications
AssigneeLafor Laboratories Limited
InventorLarry C. Ford
Life of this patent
Estimating the term…
Abstract
Micro-encapsulated lactobacilli bacteria are orally administered to mammals, including humans, to treat or prevent antibiotic associated or other chronic or acute diarrhea. Micro-encapsulated lactobacilli bacteria are topically administered to the skin to treat or prevent recurrent skin infections, and are administered intra-vaginally to treat or prevent vaginal yeast infections.
Claims4
A method of treating or preventing antibiotic associated or other acute or chronic diarrhea in a mammal, including a human being, by orally administering to said mammal in need thereof a pharmaceutical composition comprising in a unit dose thereof a therapeutically effective amount of lactobacilli bacteria sufficient to treat or prevent said diarrhea in said mammal in need thereof, said therapeutically effective amount comprising at least approximately 10.sup.3 viable lactobacilli bacteria, said bacteria being micro-encapsulated whereby the bacteria stay viable during storage of the composition, the substance providing the encapsulating coating for the bacteria being such that after ingestion by the mammal it primarily releases bacteria in the lower intestines.
Dependencies are inferred from the claim text.